ImmunoMet Therapeutics, Inc. is a biotechnology company focused on science and clinical pipelines with operations in locations including Dexter, Michigan, and Houston, Texas.
Subscribe to see Immunomet Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Immunomet Therapeutics, Inc. is a biotechnology company headquartered in Dexter, United States. It has raised at least $842,211 across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round raised $842,211 in January 2026. Xcout tracks 6 named people at Immunomet Therapeutics, Inc., including Dean Welsch (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
At least $842,211 raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $842,211 | — | |
| Series A | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Immunomet Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
ImmuneSensor Therapeutics, Inc. is a biotechnology holding company focused on drug discovery and pipelines, headquartered in Texas, United States.
ImmunoGenesis, Inc. is a clinical-stage biotechnology company headquartered in Houston, Texas, focused on re-envisioning cold tumor treatments and cancer immunotherapy research.
iOmx Therapeutics AG is a biopharmaceutical company located in Martinsried near Munich, Germany, dedicated to discovering and developing next-generation targeted cancer immunotherapies.
Invectys, Inc. is a privately owned clinical-stage biopharmaceutical and immuno-oncology company that is developing a new generation of first-in-class products. Founded in 2010 out of the Pasteur Institute, the company is headquartered in Houston, Texas.
Immune Therapeutics, Inc. is a late-stage biotechnology company with corporate executive office locations in Florida, focusing on the development of immune-regulation therapies.
ImmunoPhotonics, Inc. is a privately owned clinical-stage biopharmaceutical and pharmaceutical manufacturing company located in St. Louis, Missouri, specializing in interventional immuno-oncology.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Immunomet Therapeutics, Inc.? Suggest a correction · Work at Immunomet Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.